211 related articles for article (PubMed ID: 33331955)
21. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder.
Coetzee C; Truter I; Meyer A
Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1271-1280. PubMed ID: 33040639
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.
Pérez de los Cobos J; Siñol N; Pérez V; Trujols J
Br J Clin Pharmacol; 2014 Feb; 77(2):337-56. PubMed ID: 23216449
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD).
Perugi G; Pallucchini A; Rizzato S; De Rossi P; Sani G; Maremmani AG; Pinzone V; Maremmani I
Expert Opin Pharmacother; 2019 Feb; 20(3):343-355. PubMed ID: 30513231
[TBL] [Abstract][Full Text] [Related]
24. Quality of life of methylphenidate treatment-responsive adolescents with attention-deficit/hyperactivity disorder.
Yang PC; Lung FW; Chiou SS; Yen CF; Fuh JL
Kaohsiung J Med Sci; 2012 May; 28(5):279-84. PubMed ID: 22531308
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.
Castells X; Ramos-Quiroga JA; Rigau D; Bosch R; Nogueira M; Vidal X; Casas M
CNS Drugs; 2011 Feb; 25(2):157-69. PubMed ID: 21254791
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.
Cunill R; Castells X; Tobias A; Capellà D
J Psychopharmacol; 2015 Jan; 29(1):15-23. PubMed ID: 25142405
[TBL] [Abstract][Full Text] [Related]
27. Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men.
Moggi F; Schorno D; Soravia LM; Mohler-Kuo M; Estévez-Lamorte N; Studer J; Gmel G
Eur Addict Res; 2020; 26(4-5):233-244. PubMed ID: 32564034
[TBL] [Abstract][Full Text] [Related]
28. Detection of adult attention deficit hyperactivity disorder with cognitive complaint: Experience of a French memory center.
Pierre M; Cogez J; Lebain P; Loisel N; Lalevée C; Bonnet AL; De La Sayette V; Viader F
Rev Neurol (Paris); 2019 Jun; 175(6):358-366. PubMed ID: 31056192
[TBL] [Abstract][Full Text] [Related]
29. Attention-Deficit/Hyperactivity Disorder Symptoms, Sensation-Seeking, and Sensory Modulation Dysfunction in Substance Use Disorder: A Cross Sectional Two-Group Comparative Study.
Assayag N; Berger I; Parush S; Mell H; Bar-Shalita T
Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270233
[TBL] [Abstract][Full Text] [Related]
30. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
Fatseas M; Debrabant R; Auriacombe M
Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
[TBL] [Abstract][Full Text] [Related]
33. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features.
Spera V; Pallucchini A; Maiello M; Carli M; Maremmani AGI; Perugi G; Maremmani I
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32429586
[TBL] [Abstract][Full Text] [Related]
34. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
[TBL] [Abstract][Full Text] [Related]
35. Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.
Lupattelli A; Chambers CD; Bandoli G; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2019 Apr; 2(4):e191435. PubMed ID: 30951155
[TBL] [Abstract][Full Text] [Related]
36. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
Schubiner H
CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.
Riggs PD; Winhusen T; Davies RD; Leimberger JD; Mikulich-Gilbertson S; Klein C; Macdonald M; Lohman M; Bailey GL; Haynes L; Jaffee WB; Haminton N; Hodgkins C; Whitmore E; Trello-Rishel K; Tamm L; Acosta MC; Royer-Malvestuto C; Subramaniam G; Fishman M; Holmes BW; Kaye ME; Vargo MA; Woody GE; Nunes EV; Liu D
J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):903-14. PubMed ID: 21871372
[TBL] [Abstract][Full Text] [Related]
38. Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.
van der Kolk A; Bouwmans CA; Schawo SJ; Buitelaar JK; van Agthoven M; Hakkaart-van Roijen L
J Ment Health Policy Econ; 2014 Sep; 17(3):119-29. PubMed ID: 25543115
[TBL] [Abstract][Full Text] [Related]
39. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
[TBL] [Abstract][Full Text] [Related]
40. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
Wilson JJ; Levin FR
J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
